DR. JONATHAN W WONG, DDS MS
Dentist at 8 St, Chicago, IL
License number
Illinois 019027637
Category
Dentist
Type
General Practice
Address
Address
41 E 8Th St APT 3206, Chicago, IL 60605
Phone
(773) 575-1018
Professional information
Jonathan Wong - Chicago, IL
Work:
Coyote Logistics
National Account Manager Southern Tide - University Park, PA
College Ambassador Communication Arts and Science Research - University Park, PA
Research Assistant Pandigital Inc - Dublin, CA
Marketing Intern
National Account Manager Southern Tide - University Park, PA
College Ambassador Communication Arts and Science Research - University Park, PA
Research Assistant Pandigital Inc - Dublin, CA
Marketing Intern
Education:
The Pennsylvania State University - University Park, PA
Bachelor of Arts in Communication Arts & Sciences
Bachelor of Arts in Communication Arts & Sciences
Skills:
Sales, Marketing, Blogging, Social Media, Market Research, Microsoft Office, Multitask
Student At University Of Illinois
Location:
Greater Chicago Area
Industry:
Medical Practice
Education:
University of Illinois at Urbana-Champaign 2004 - 2008
Ex Vivo And In Vivo Expression Of The Thrombomodulin Gene For The Treatment Of Cardiovascular And Peripheral Vascular Diseases
US Patent:
7670597, Mar 2, 2010
Filed:
Aug 15, 2006
Appl. No.:
11/464712
Inventors:
Lakshman R. Sehgal - Glenview IL, US
Jonathan Wong - Chicago IL, US
Jonathan Wong - Chicago IL, US
Assignee:
Biovec, LLC - Chicago IL
International Classification:
A01N 63/00, A61K 39/235
US Classification:
424 936, 4242331, 514 44 R
Abstract:
The present invention relates to methods and compositions for treatment of cardiovascular and peripheral vascular diseases using ex vivo and in vivo gene delivery technologies. One aspect of the present invention relates to a method for treating a vascular disease by introducing a DNA sequence encoding a TM protein or its variant into a segment of a blood vessel ex vitro using a gutless adenovirus vector. Another aspect of the present invention is to provide a method to deliver a gutless adenovirus vector carrying a DNA sequence encoding a TM protein or its variant using a stent.
Ex Vivo And In Vivo Expression Of The Thrombomodulin Gene For The Treatment Of Cardiovascular And Peripheral Vascular Diseases
US Patent:
2004019, Oct 7, 2004
Filed:
Dec 2, 2003
Appl. No.:
10/725013
Inventors:
Lakshman Sehgal - Glenview IL, US
Jonathan Wong - Chicago IL, US
Jonathan Wong - Chicago IL, US
International Classification:
A61K048/00
US Classification:
514/044000, 424/093200
Abstract:
The present invention relates to methods and compositions for treatment of cardiovascular and peripheral vascular diseases using ex vivo and in vivo gene delivery technologies. One aspect of the present invention relates to a method for treating a vascular disease by introducing a DNA sequence encoding a TM protein or its variant into a segment of a blood vessel ex vitro using a gutless adenovirus vector. Another aspect of the present invention is to provide a method to deliver a gutless adenovirus vector carrying a DNA sequence encoding a TM protein or its variant using a stent.
Therapeutic Applications Of Thrombomodulin Gene Via Viral And Non-Viral Vectors
US Patent:
2005010, May 19, 2005
Filed:
Feb 25, 2004
Appl. No.:
10/785156
Inventors:
Lakshman Sehgal - Glenview IL, US
Jonathan Wong - Chicago IL, US
Prem Seth - Glenview IL, US
Jonathan Wong - Chicago IL, US
Prem Seth - Glenview IL, US
International Classification:
A61K048/00, C12N015/861
US Classification:
424093200, 435456000
Abstract:
The present invention relates to methods and compositions for treating thrombotic diseases using gene delivery technologies. In one embodiment, a therapeutically effective amount of a TM gene product is expressed in a TM-deficient mammal using a viral or non viral vector. In another embodiment, the vector-mediated in vivo TM gene expression is used for the treatment of atherosclerotic cardiovascular disease, pulmonary hypertension, acute inflammatory diseases, end-stage renal failure disease, or Alzheimer disease. In yet another embodiment, a vector carrying a TM inhibitory polynucleotide in which the vector is introduced into a mammal to reduce the TM activity or TM gene expression in vivo.